MYL-1701P displayed similar efficacy, safety, and immunogenicity when compared with reference aflibercept to treat diabetic macular edema. Aflibercept is an intravitreal drug approved by the FDA ...

MYL state treasurer Ismail P Wayanad said a total of 25,000 members will complete the course in six month. MALAPPURAM: Muslim Youth League (MYL), the youth wing of the Indian Union Muslim League ...

A sardonic attempt made by Muslim Youth League (MYL) activists to paste ‘look-out notices’ against Chief Minister Pinarayi Vijayan at the Kerala Police Headquarters here on Saturday turned ...

Panakkad Sayyid Munavvarali Shihab Thangal and P.K. Firos were re-elected president and general secretary of the Muslim Youth League (MYL), an affiliate of the Indian Union Muslim League (IUML ...

The focea in natural behaviors The fact that mice have a focea could mean that they also move their eyes to point their focea at interesting parts of world, analogous to the human fovea.

Researchers from the Netherlands Institute of Neuroscience (NIN) have shown that the visual cortex of mice does contain a region of enhanced visual sensitivity dubbed the 'focea', making the mouse ...

Going by the historical performance, we believe that the stock price of Mylan (NYSE: MYL), a pharmaceutical company best known for its generic drugs, could offer an upside of over 45% from the ...

Mylan N.V. MYL and partner Fujifilm Kyowa Kirin Biologics Co., Ltd. announced that the FDA has approved a biosimilar of blockbuster drug, Humira (adalimumab-fkjp), under the brand name Hulio.

Shares of Mylan were up 6% in trading on Thursday after the drugmaker restarted production of hydroxychloroquine-sulfate tablets, which are being considered as a possible treatment for people with ...

Mylan N.V. MYL is expected to beat on earnings in fourth-quarter 2019. The company’s performance has been pretty good so far, with an earnings beat in three of the trailing four quarters and a ...

Mylan N.V. MYL and partner Biocon Ltd. announced the launch of Ogivri (trastuzumab-dkst), a biosimilar of Roche’s RHHBY blockbuster breast cancer drug, Herceptin (trastuzumab), in the United ...